Task force on the management of chest pain

• Published in: European heart journal Vol. 23; no. 15; pp. 1153 - 1176
• Main Authors: Erhardt, L., Herlitz, J., Bossaert, L., Halinen, M., Keltai, M., Koster, R., Marcassa, C., Quinn, T., van Weert, H.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01-08-2002
• Subjects: Advisory Committees; Ambulances; Biological and medical sciences; Biological Markers: analysis; Biomarkers - analysis; Cardiac and Cardiovascular Systems; Cardiology. Vascular system; Cardiovascular: standards; Chest Pain - diagnosis; Chest Pain - epidemiology; Chest Pain - etiology; Chest Pain - therapy; Clinical Medicine; Coronary heart disease; Diagnostic Techniques; Diagnostic Techniques, Cardiovascular - standards; Electrocardiography; Emergency Medical Services; Europe - epidemiology; Family; Female; Health Care; Heart; Heart Diseases - diagnosis; Heart Diseases - epidemiology; Heart Diseases - etiology; Heart Diseases - therapy; Hospitals; Human; Humans; Kardiologi; Klinisk medicin; Male; Medical and Health Sciences; Medical sciences; Medicin och hälsovetenskap; Patient Education; Patient Education as Topic; Physicians; Physicians, Family; Quality Assurance; Quality Assurance, Health Care; Time Factors; Europe; Human; Electrodiagnosis; Treatment; Decision making; Electrocardiography; Cardiovascular disease; Diagnosis; Angina pectoris; Thoracic pain; Coronary heart disease; Bibliographic review
• ISSN: 0195-668X; 1522-9645; 1522-9645
• DOI: 10.1053/euhj.2002.3194

The Task Force on the management of chest pain was created by the committee for Scientific and Clinical Initiatives on 28 June 1997 after formal approval by the Board of the European Society of Cardiology. The document was circulated to the members of the Committee for Scientific and Clinical Initiatives, to the members of the Board and to the following reviewers: J. Adgey, C. Blomstro¨m-Lundqvist, R. Erbel, W. Klein, J. L. Lopez-Sendon, L. Ryde´n, M. L. Simoons, C. Stefanadis, M. Tendera, K. Thygesen. After further revision it was submitted for approval to the Committee for Practise Guidelines and Policy Conferences. The Task Force Report was supported financially in its entirety by The European Society of Cardiology and was developed without any involvement of the pharmaceutical industry.